Zobrazeno 1 - 10
of 296
pro vyhledávání: '"Akihiko, Yokohama"'
Autor:
Tatsuo Horiuchi, Tomonori Takazawa, Shinya Sakamoto, Masaki Orihara, Akihiko Yokohama, Mutsumi Uchiyama, Shigeru Saito
Publikováno v:
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-4 (2021)
Abstract Background Sugammadex is a synthetic γ-cyclodextrin derivative designed to selectively bind to steroidal neuromuscular blocking agents and reverse their effects. Although many cases of sugammadex-induced anaphylaxis have been reported, few
Externí odkaz:
https://doaj.org/article/f0cf3f9047f443b5a1ee78bec540bb3b
Autor:
Noriyuki Takahashi, Takayuki Saitoh, Nanami Gotoh, Yasuhiro Nitta, Lobna Alkebsi, Tetsuhiro Kasamatsu, Yusuke Minato, Akihiko Yokohama, Norifumi Tsukamoto, Hiroshi Handa, Hirokazu Murakami
Publikováno v:
BMC Immunology, Vol 18, Iss 1, Pp 1-11 (2017)
Abstract Background T-helper cell type 1 (Th1) polarization in chronic immune thrombocytopenia (cITP) has been reported at the protein and mRNA levels. We evaluated the impact of Th1/Th2 cytokine and cytokine receptor functional polymorphisms on both
Externí odkaz:
https://doaj.org/article/564407817b7e4265a9a5e4e2eec76701
Autor:
Reina Ishikawa, Takayuki Maruhashi, Kozue Susa, Natsumi Nishimoto, Kanae Iwahara, Hideki Goto, Osamu Ishikawa, Akira Hayakawa, Yoichiro Takahashi, Rie Sano, Yoshihiko Kominato, Akihiko Yokohama
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 68:428-434
Autor:
Maaya Awata-Shiraiwa, Akihiko Yokohama, Yukihiro Kanai, Nanami Gotoh, Tetsuhiro Kasamatsu, Hiroshi Handa, Takayuki Saitoh, Hirokazu Murakami, Junko Hirato, Hayato Ikota, Norifumi Tsukamoto
Publikováno v:
Acta Haematologica.
Introduction Waldenström macroglobulinemia (WM) represents a subset of lymphoplasmacytic lymphoma (LPL) with the immunoglobulin (Ig)M paraprotein. MYD88 L265P and CXCR4 mutations are common mutations in WM patients, and mutations in ARID1A and KMT2D
Autor:
Akira Hayakawa, Rie Sano, Yoichiro Takahashi, Takafumi Okawa, Rieko Kubo, Megumi Harada, Haruki Fukuda, Akihiko Yokohama, Hiroshi Handa, Reika Kawabata‐Iwakawa, Hatsue Tsuneyama, Junichi Tsukada, Yoshihiko Kominato
Publikováno v:
Transfusion. 62:469-480
Reduction of blood group ABO antigens on red blood cells (RBCs) is well known in patients with leukemias, and this reduction of ABO expression is strongly associated with DNA methylation of the ABO promoter. Previously, we reported a two-nucleotide d
Autor:
Yuri Miyazawa, Hisashi Takei, Nobuhiko Kobayashi, Naoki Akashi, Yukiko Sairenji, Manato Sugisaki, Chiaki Naito, Tetsuya Ishikawa, Hiroaki Shimizu, Takuma Ishizaki, Akihiko Yokohama, Norifumi Tsukamoto, Yuka Yoshida, Nozomi Matsumura, Yoshiyasu Takayama, Hiroshi Handa
Publikováno v:
Journal of clinical and experimental hematopathology : JCEH. 62(4)
Bone marrow necrosis (BMN) occurs most frequently in hematological malignancies and sometimes in non-hematological disorders. Lymphoid diseases causing necrosis are regarded as high-grade disease. B-lymphoblastic leukemia/lymphoma is the most common
Autor:
Nobuharu Fujii, Misao Abe, Hiroaki Ogo, Laura Cooling, Akihiko Yokohama, Yurika Yazawa, Hitoshi Ohto, Yoshiko Tamai, Yasunori Ueda, Takaaki Hato, Kenneth E. Nollet, Akihiro Takeshita, Kinuko Mitani, Keijiro Suzuki, Junichi Kitazawa, Midori Kumagawa, Hiroyasu Yasuda, Yoko Kato
Publikováno v:
Transfusion
Background Anti‐M is frequently observed as a naturally occurring antibody of little clinical significance. Naturally occurring anti‐M is often found in children although the specific triggers of production, persistence, and evanescence of anti
Autor:
Tetsuhiro Kasamatsu, Maaya Awata-Shiraiwa, Rei Ishihara, Yuki Murakami, Yuta Masuda, Nanami Gotoh, Tsukasa Oda, Akihiko Yokohama, Ikuko Matsumura, Hiroshi Handa, Norifumi Tsukamoto, Hirokazu Murakami, Takayuki Saitoh
Cellular senescence refers to a pause in the cell cycle, usually in response to internal and/or external stress, including telomere dysfunction, abnormal cellular growth, and DNA damage. Several chemotherapeutic drugs, such as melphalan (MEL) and dox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b22ab39c17f040e6f75602f9bd14e57
https://doi.org/10.21203/rs.3.rs-2058604/v1
https://doi.org/10.21203/rs.3.rs-2058604/v1
Autor:
Masahiko Kamimura, Keiko Yokote, Noriko Matsumoto, Ken-ichi Maruyama, Shiori Onuma, Kumi Fukami, Takayuki Maruhashi, Akihiko Yokohama, Makoto Terada, Megumi Imai, Fumie Nakanishi, Keita Sakakura, Tomomi Inokoshi, Hiroshi Ito, Hiroko Suzuki
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 67:53-57
Autor:
Shigeyoshi Makino, Akihiko Yokohama, Asashi Tanaka, Yuichi Hasegawa, Kazuo Muroi, Keizo Fujino, Akihiro Takeshita, Kazuhiko Ikeda, Shin-ichiro Fujiwara, Shuichi Kino, Mayumi Matsumoto
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 67:58-64
In the Japan Marrow Donor Program (JMDP), autologous blood is collected from most unrelated bone marrow (BM) donors. We retrospectively evaluated 5772 donors who underwent BM harvest between 2010 and 2015 through the JMDP. Autologous blood was collec